
Power Up Your Morning with iBIO NewsBrief!
Get the daily email that keeps you informed and connected in the life sciences industry
Â
📲 READ THE LATEST NEWSLETTER
iBIO IN THE NEWS
PRESS RELEASES AND BLOGS
GRANT REPORT: Critical Federal Funding Opportunities Amidst Changing Landscape
A Year of Growth and Innovation: iBIO Leadership Reflects on 2024 Achievements
New Report Highlights Illinois Life Sciences Industry’s Remarkable Growth and Economic Impact
Navigating Political Crosswinds: Investment and Innovation in Life Sciences
MEMBER NEWS
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment
The Growing Crisis of Antimicrobial Resistance: Meitheal Takes Action with XENLETA®
POLICY NEWS
iBIO Statement on President Trump’s Recent Executive Order Addressing Drug Pricing
Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem
Healthcare Policy Faces Crossroads in Today’s Election
Medicare Drug “Negotiations” 2.0: Key Changes You Need to Know
ALL NEWS
iBIO Statement on President Trump’s Recent Executive Order Addressing Drug Pricing
iBIO recognizes the significance of the Trump Administration's recent Executive Order addressing...
GRANT REPORT: Critical Federal Funding Opportunities Amidst Changing Landscape
In partnership with G2G Consulting, iBIO is pleased to provide members with the March 2025...
Council on State Biotechnology Associations says NIH funds are a critical component of innovation ecosystem
“Today, the US biotech industry employs nearly 2.3 million people across the US and is making...
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
In partnership with G2G Consulting, we are please to provide the January 2025 Grants report,...
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Chicago-based Xentria advances Illinois' position in life sciences innovation through strategic...